临床咨询:药剂师在状尿素治疗状细胞疾病中的作用
Cameron Roessner1, Kelsey Uminski2, Dawn Goodyear2
1Southern Alberta Rare Blood and Bleeding Disorders Comprehensive Care Program, Foothills Medical Center, Calgary, AB, and Pharmacy Services, Foothills Medical Center, Calgary, AB, Canada.
概括
氧尿素是状细胞疾病 (SCD) 的关键治疗方法,改善了患者的治疗结果. 药剂师的干预措施通过改善粘附性和优化剂量以更好地管理SCD,显著提高基尿素的有效性.
科学领域:
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 状细胞疾病 (SCD) 是一种遗传疾病,源于β-环球蛋白基因的突变,导致状血红蛋白 (HbS) 异常.
- 氧尿素是SCD的关键疾病修饰疗法,已知可以增加胎儿血红蛋白 (HbF) 产量.
研究的目的:
- 探索基尿素在控制状细胞疾病 (SCD) 中的作用.
- 检查药剂师主导的干预措施如何优化氧尿素的使用并改善SCD患者的治疗结果.
主要方法:
- 对SCD中基尿素治疗的临床咨询数据的审查.
- 对药剂师干预措施的分析,包括患者教育,实验室监测和剂量定位到最大耐受剂量 (MTD).
- 评估表明药剂师管理协议对遵守,MTD成就和临床结果的影响的研究.
主要成果:
- 基尿素有效降低HbS聚合,导致较少的血管封闭性危机和急性胸部综合征.
- 药剂师管理的协议显著改善了患者的坚持,并增加了患者达到MTD的比例.
- 由药剂师指导的优化尿素治疗,导致HbF水平更高,住院病例减少.
结论:
- 氧尿素仍然是SCD的基石疗法,尽管出现了像基因疗法这样的新疗法.
- 药剂师在克服基尿素使用障碍方面至关重要,例如缺乏粘附性和低于最佳剂量的剂量.
- 加强药剂师参与SCD管理对于最大限度地提高基尿素的益处和改善长期患者的结果至关重要.
相关概念视频
01:28Esophageal Varices-II: Clinical Features and Management
50
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
50
01:11Renal Failure: Dose Adjustments
68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
01:26Drug Administration and Therapy Phases: Overview
416
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
416
01:15Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
01:19Nonlinear Pharmacokinetics: Overview
309
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
309
01:17Factors Affecting Renal Clearance: Renal Impairment
61
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
61